Polymorphisms of platelet membrane glycoprotein Ibα associated with arterial thrombotic disease

Blood

Volumn 92, Issue 8, 1998, Pages 2771-2776

  Gonzalez Conejero, Rocio ^b   Lozano, Maria L ^b   Rivera, Jose ^b   Corral, Javier ^b   Iniesta, Juan A ^b   Moraleda, Jose M ^b   Vicente, Vicente ^a  

^a HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0032532036     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.8.2771     Document Type: Article

References (55)

1. Wu KK, Hoak JC: Spontaneous platelet aggregation in arterial insufficiency: Mechanisms and implication. Thromb Haemost 35:702, 1976
2. Trip MD, Cats VM, van Capelle FJ, Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 323;1549, 1990
3. Report of a meeting of Physicians and Scientists, University of Texas Health Science Center at Houston and Texas Heart Institute, Houston. Platelet activation and arterial thrombosis. Lancet 344:991, 1994
4. Konstantopoulos K, Grotta JC, Sills C, Wu KK, Hellums JD: Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost 74:1329, 1995
5. Dewitz TS, Martin RR, Solis RT, Heliums JD, McIntire LV: Microaggregate formation in whole blood exposed to shear stress. Microvasc Res 16:263, 1978
6. Jen CJ, McIntire LV: Characteristics of shear-induced aggregation in whole blood. J Lab Clin Med 103:115, 1984
7. O'Brien JR: Shear-induced platelet aggregation. Lancet 335:711, 1990
8. Razdan K, Hellums JD, Kroll MH: Shear stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 302:681, 1994
9. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL: Platelets and shear stress. Blood 88:1525, 1996
10. López JA: The platelet glycoprotein Ib-IX complex. Blood Coag Fibrinol 5:97, 1994
11. Moroi M, Jung S, Yoshida N: Genetic polymorphism of platelet glycoprotein Ib. Blood 64:622, 1984
12. López JA, Ludwig EH, McCarthy BJ: Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. J Biol Chem 267:10055, 1992
13. 145. Blood 86:1356, 1995
14. Kuijpers RWAM, Faber NM, Cuypers HTM, Ouwehand WH, von dem Borne AEGK: The N-terminal globular domain of human platelet glycoprotein Ibα has a methionine 145/threonine 145 amino acid polymorphism which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 89:381, 1992
15. Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM: Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood 79:3086, 1992
16. Vicente V, Houghten RA, Ruggeri ZM: Identification of a site in the a chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 265:274, 1990
17. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM: Localization and characterization of an α-thrombin-binding site on platelet glycoprotein Ibα. J Biol Chem 269:6478, 1994
18. Simsek S, Bleeker PMM. van der School CE. von dem Borne AEGK: Association of a variable number of tandem repeats (VNTR) in glycoprotein Ibα and HPA-2 alloantigens. Thromb Haemost 72:757, 1994
19. Jung SM, Plow EF, Moroi M: Polymorphism of platelet glycoprotein Ib in the United States. Thromb Res 42:83, 1986
20. Muñiz-Díaz E, Arilla M, Ibáñez M, Bosch MA, Pastoret C, Madoz P: [Frequency of platelet alloantigens in Spain]. Frecuencia de los aloantígenos de las plaquetas en población española. Sangre 4:289, 1993
21. Kaski S, Kekomäki R, Partanen J: Systematic screening for genetic polymorphism in human platelet glycoprotein Ib alpha. ImmuHopnetics 44:170, 1996
22. 145 dimorphism in platelet glycoprotein Ibα in Italian population. Transfusion 36:891, 1996
23. Special Report From the National Institute of Neurological Disorders and Stroke: Classification of Cerebrovascular Diseases III. Stroke 21:637, 1990
24. World Health Organization: Ischemic Heart Disease Registers: Report of the Fifth Work Group, Including a Second Revision of the Operating Protocol, Copenhagen, Denmark, April 26-29, 1971. Copenhagen, Denmark, World Health Organization, Regional Office for Europe, 1971
25. Corral J, Iniesta JA, González-Conejero R, Vieente V: Detection of factor V Leiden from a drop of blood by PCR-SSCP. Thromb Haemost 76:735, 1996
26. Corral J, González-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V: The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not associated with arterial disease. Br J Haematol 99:304, 1997
27. Wenger RH, Kieffer N, Wicki AN, Clemetson KJ: Structure of human blood platelet membrane glycoprotein Ib alpha gene. Biochem Biophys Res Commun 156:389, 1988
28. Peyruchuud O, Nurden A, Bourre F: Non-radiactive SSCP for genotyping human platelet alloamigens. Br J Haematol 89:633, 1995
29. Green F, Humphries S: Genetic determinants of arterial thrombosis. Clin Haematol 7:675, 1994
30. Clarke R, Daly L, Robinson K: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149, 1991
31. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641, 1992
32. Di Minno G, Grandone E, Margaglione M: Clinical relevance of polymorphic markers of arterial thrombosis. Thromb Haemost 78:462, 1997
33. Rosendaal FR, Siscovick DS, Schwarrtz SM, Psaty BM, Raghunathan TE, Vos HL: A common prothombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 90:1747, 1997
34. Rosendaal FR, Siscovick DS, Schwarrtz SM, Beverly RK, Psaty BM, Longstreth WT, Raghunathan TE, Koepsell TD, Reitsma PH: Factor V Leiden fresistence to activated protein C) increases the risk of myocardial infarction in young women). Blood 89:2817, 1997
35. Iacoviello L, Castelnuovo A, Knijff P, D'Orazio A, Amore C, Arboretti R, Kluft C, Donati MB: Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 338:79, 1998
36. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ: Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79:8, 1998
37. Behague Y, Poirier O, Nicaud V, Evans A, Arvelier D, Luc G, Cambou JP, Scarabin PY, Bara L, Green F, Cambien F: Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Etude Cas-Temoins sur l' Infarctus du Myocarde. Circulation 3:440, 1996
38. Wenzel K, Felix S, Kleber FX, Brachold R, Menke T, Schattke S, Schulte KL, Gläser C, Rohde K, Baumann G, Speer A: E-selectin polymorphism and atherosclerosis: An association study. Hum Mol Gen 3:1935, 1994
39. Norlund L, Holm J, Zöller B, Öhlin AK: A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 77:248, 1997
40. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA: Thrombomodulin gene mutations associated with myocardial infarction. Circulation 96:15, 1997
41. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler T, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont J: A polymorphism of a platelet glycoprotcin receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090, 1996
42. Corral J, González-Conejero R, Rivera J, Iniesta JA, Lozano ML, Vicente V: HPA-1 genotype in arterial thrombosis - Role of HPA-lb polymorphism platelet function. Blood Coag Fibrinol 8:284. 1997
43. Carter AM, Osseei-Gerning N, Grant PJ: Platelet glyeoprotein IIIa PLA polymorphism in young men with myocardial infarction. Lancet 347:485, 1996
44. A polymorphism and myocardial infarction [letter]. N Engl J Med 335:1071, 1996
45. Al/A2 polymorphism of platelet glyeoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349:385, 1997
46. Carter AM, Ossei GN, Wilson IJ, Grant PJ: Association of the platelet Pl( A) polymorphism of glyeoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 96:1424, 1997
47. Samani NJ, Lodwick D: Glyeoprotein Ilia polymorphism and risk of myocardial infarction. Cardiovas Res 33:693, 1997
48. Newman PJ: Platelet alloantigens: Cardiovascular as well as immunological risk factors? Lancet 349:370, 1997
49. Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y: Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 96:3281, 1997
50. Nurden AT: Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance. Thromb Haemost 74:345, 1995
51. Strony J, Phillips M, Brands D, Moake J, Adelman B: Aurintricarboxylic acid in a canine model of coronary artery thrombosis. Circulation 81:1106, 1990
52. Girma GP, Fressinaud E, Christophe O Rouault C, Obert B, Takahashi Y, Meyer D: Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glyeoprotein Ib. Thromb Haemost 68:707, 1992
53. Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, Mclntire LV: Real-time analysis of shear dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81:1263, 1993
54. Bernat A, Lale A, Herbert JM: Aurin tricarboxylic acid inhibits experimental venous thrombosis. Thromb Res 74:617, 1994
55. Strony J, Song A, Rusterholtz L, Adelman B: Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis. Arterioscler Thromb Vase Biol 15:359, 1995